ATF4 and cancer: The data show that, when cancer cells were treated with Wnt3a, ATF4 did not further enhance the activity of canonical Wnt signaling, which suggests that ATF4 regulates Wnt/β-catenin signaling mainly through modulating β-catenin stability, similar to Wnt3a.